Understanding the Cost of GLP-1 Medications in Canada

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss medications like semaglutide and tirzepatide have transformed metabolic health outcomes, with clinical trials showing 15–22% body weight reduction over 68 weeks. Canadian patients historically faced limited access and high out-of-pocket costs, but compounded GLP-1 options now provide affordable pathways to treatment. Understanding the cost landscape helps you make an informed decision about your weight loss journey.

How GLP-1 Medication Pricing Works in Canada

PlexusDx offers GLP-1 medications through licensed 503A compounding pharmacies that serve all Canadian provinces without requiring insurance or membership fees. Unlike brand-name pharmaceuticals, compounded medications are manufactured to exacting standards at a fraction of retail cost. Your dose may need to go up as your body responds to treatment, but PlexusDx pricing remains fixed—ensuring predictable, transparent monthly costs.

Canadian healthcare varies by province; some provinces cover certain weight loss medications under specific criteria, while others do not. PlexusDx provides direct access independent of provincial insurance decisions, making treatment available to anyone willing to pay out-of-pocket. This model eliminates wait times and gives Canadian patients the same treatment options available to Americans.

PlexusDx GLP-1 Treatment Options and Monthly Costs

PlexusDx offers five core GLP-1 products at different price points. The Microdose GLP-1 Protocol starts at $129 per month and serves patients seeking a gentler introduction to weight loss therapy with lower initial side effects. Compounded Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan, while Oral Semaglutide is $289 monthly. Patients ready for dual-action therapy can choose Compounded Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan) or Oral Tirzepatide at $349/mo (or $279/mo on the 6-month plan).

For advanced metabolic support, the GLP-Squared line combines semaglutide and tirzepatide in one injection (starting at $289/mo) or oral formula (starting at $389/mo). All medications come from licensed 503A compounding pharmacies and qualify for HSA and FSA accounts, further reducing your actual out-of-pocket burden. PlexusDx also offers the Precision Peptide Genetic Test for $298, describing the pathway-level variants involved.

Why Canadian Patients Choose Compounded GLP-1 Over Brand Options

Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) typically cost $300–$500 per month in Canada without insurance coverage, and many patients face multi-month wait times through provincial health systems. Compounded alternatives deliver pharmaceutical-grade active ingredients at 40–60% lower cost, with no wait time and no insurance approval needed. PlexusDx patients in British Columbia, Ontario, Alberta, and Quebec receive shipments within days.

Compounded medications must meet the same purity and potency standards as brand pharmaceuticals but avoid the marketing and distribution overhead of major pharmaceutical companies. Canadian patients often discover they save money while gaining personalized dosing flexibility and genetic insight into their individual response patterns through PlexusDx's precision testing.

Personalized Genetic Testing and Your Treatment Plan

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I get GLP-1 medications shipped to my address in Canada?

Yes. PlexusDx serves all 50 U.S. states and all Canadian provinces through licensed 503A compounding pharmacies. Patients receive shipments directly without insurance requirements or membership fees, making treatment accessible regardless of provincial health coverage policies.

What clinical evidence supports GLP-1 therapy for weight loss?

Multiple randomized controlled trials confirm GLP-1 receptor agonists produce sustained weight loss of 15–22% over 68 weeks, with improved cardiovascular outcomes and reduced type 2 diabetes risk. Both semaglutide and tirzepatide have demonstrated safety profiles in clinical populations, though individual responses vary based on genetics and lifestyle factors.

Does PlexusDx pricing increase if my dose goes up?

No. PlexusDx uses a flat monthly fee structure; your dose may need to go up as your body adapts to therapy, but your price won't. This transparency eliminates the surprise of dose-based billing seen with some competitors, making long-term budgeting predictable.

What side effects should I expect when starting GLP-1 therapy?

Common early side effects include nausea, constipation, and mild fatigue, which typically decrease within 2–4 weeks as your body adjusts. The Microdose GLP-1 Protocol ($129/mo) specifically minimizes initial nausea through lower starting doses. Serious adverse events are rare but can include pancreatitis or gallbladder issues; PlexusDx clinicians screen for risk factors before initiating therapy.

How does the Precision Peptide Genetic Test improve my outcomes?

The test identifies which of your 49 key metabolic peptides respond best to GLP-1 therapy, allowing PlexusDx clinicians to select semaglutide, tirzepatide, or the dual-compound GLP-Squared protocol based on your unique genetics. Patients with predictable responder profiles often achieve weight loss goals 30–50% faster than trial-and-error approaches.

Related Reading

• Glp 1 Cost 2
• Eden Glp 1 Cost Plexusdx
• Glp 1 Cost Plexusdx
• Glp 1 Cost

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.